| Sex work and related issues | Lifetime | 5 | US 4 | 99.81 |
| HIV, Drug Use, Sexual Risk | Lifetime | 12 | US 7 | 99.82 |
| HIV/AIDS Research and Interventions | Lifetime | 34 | US 21 | 99.83 |
| Adolescent Sexual and Reproductive Health | Lifetime | 23 | US 16 | 99.71 |
| HIV Research and Treatment | Lifetime | 447 | US 273 | 98.81 |
| HIV/AIDS drug development and treatment | Lifetime | 977 | US 482 | 97.07 |
| Blood groups and transfusion | Lifetime | 781 | US 351 | 95.84 |
| LGBTQ Health, Identity, and Policy | Lifetime | 311 | US 202 | 96.17 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 951 | US 390 | 95.79 |
| Data-Driven Disease Surveillance | Lifetime | 261 | US 128 | 94.43 |
| Syphilis Diagnosis and Treatment | Lifetime | 428 | US 202 | 93.21 |
| SARS-CoV-2 detection and testing | Lifetime | 794 | US 216 | 90.78 |
| Sexuality, Behavior, and Technology | Lifetime | 785 | US 403 | 91.81 |
| Public Health Policies and Education | Lifetime | 513 | US 345 | 88.42 |
| Healthcare Systems and Challenges | Lifetime | 415 | US 63 | 75.58 |
| Health Services Management and Policy | Lifetime | 365 | US 61 | 72.85 |
| Focus Groups and Qualitative Methods | Lifetime | 804 | US 340 | 29.12 |
| HIV/AIDS Research and Interventions | 2021-2025 | 5 | US 3 | 99.79 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 4 | US 2 | 99.81 |
| Sex work and related issues | 2021-2025 | 7 | US 3 | 99.39 |
| Adolescent Sexual and Reproductive Health | 2021-2025 | 29 | US 8 | 98.97 |
| HIV Research and Treatment | 2021-2025 | 110 | US 50 | 97.08 |
| COVID-19 epidemiological studies | 2021-2025 | 439 | US 89 | 94.62 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 496 | US 168 | 93.93 |
| LGBTQ Health, Identity, and Policy | 2021-2025 | 413 | US 259 | 89.21 |
| Health Policy Implementation Science | 2021-2025 | 638 | US 270 | 85.66 |
| Mobile Health and mHealth Applications | 2021-2025 | 930 | US 261 | 83.20 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 749 | US 181 | 80.28 |
| Syphilis Diagnosis and Treatment | 2021-2025 | 300 | US 107 | 80.01 |
| HIV/AIDS Impact and Responses | 2021-2025 | 827 | US 195 | 48.15 |
| ICT in Developing Communities | 2021-2025 | 717 | US 178 | 18.55 |
